Litcius/Paper detail

Advances in Recurrent Stroke Prevention: Focus on Antithrombotic Therapies

Brian Mac Grory, Shadi Yaghi, Charlotte Cordonnier, Luciano A. Sposato, Jose G. Romano, Seemant Chaturvedi

2022Circulation Research27 citationsDOIOpen Access PDF

Abstract

The past decade has seen significant advances in stroke prevention. These advances include new antithrombotic agents, new options for dyslipidemia treatment, and novel techniques for surgical stroke prevention. In addition, there is greater recognition of the benefits of multifaceted interventions, including the role of physical activity and dietary modification. Despite these advances, the aging of the population and the high prevalence of key vascular risk factors pose challenges to reducing the burden of stroke. Using a cause-based framework, current approaches to prevention of cardioembolic, cryptogenic, atherosclerotic, and small vessel disease stroke are outlined in this paper. Special emphasis is given to recent trials of antithrombotic agents, including studies that have tested combination treatments and responses according to genetic factors.

Topics & Concepts

AntithromboticMedicineStroke (engine)Intensive care medicineDyslipidemiaFibrinolytic agentClinical trialPopulationDiseasePhysical therapyObservational studyVascular diseasePhysical medicine and rehabilitationMEDLINESecondary preventionBioinformaticsArterial diseaseFocus (optics)Global populationPlatelet aggregation inhibitorIschemic strokeRandomized controlled trialReview articleNeurovascular bundleNeurological Disease Mechanisms and TreatmentsNeurological Disorders and TreatmentsAcute Ischemic Stroke Management
Advances in Recurrent Stroke Prevention: Focus on Antithrombotic Therapies | Litcius